Abstract
Multiple-unit type oral modified drug delivery system of aceclofenac was developed by ionotropic gelation method for targeted drug delivery and to reduce the chances of side effects. Various batches of microspheres were developed by ionotropic gelation method using single and blends of polymers. Along with usual physical properties, the microspheres were also subjected to enteric nature, in-vitro drug release and mucoadhesion studies to investigate a possible sustained drug release and their use in in-vivo as a gastro-protective system for aceclofenac. It was observed that prepared microspheres could be able to restrict the drug release in stomach region and prolong the drug release by adhering on to the intestinal mucosa. In vitro drug release suggested a combination of drug diffusion and spheres erosion could be the release mechanism and it was also found that blend of polymers is more effective in sustaining the drug release than either polymer. Optimized microsphere formulation suggested 71.03 ± 4.94 % edema inhibition at 12 hours and shelf life of about 2.32 years at room temperature. Algino-gelatin multiunit dosage system exhibits promising properties for once daily targeted release form of aceclofenac in order to reduce the side effects and enhance the patient’s compliance.
Keywords: Algino-gelatin microspheres, enteric nature, gastro-protection, in-vivo study, mucoadhesion, targeted release.
Drug Delivery Letters
Title:Design, Characterization and Pre-Clinical Evaluation of Aceclofenac Loaded Algino-gelatin Microspheres for Targeted Drug Delivery
Volume: 3 Issue: 2
Author(s): Santanu Chakraborty, Madhusmruti Khandai and Ashoke Kumar Ghosh
Affiliation:
Keywords: Algino-gelatin microspheres, enteric nature, gastro-protection, in-vivo study, mucoadhesion, targeted release.
Abstract: Multiple-unit type oral modified drug delivery system of aceclofenac was developed by ionotropic gelation method for targeted drug delivery and to reduce the chances of side effects. Various batches of microspheres were developed by ionotropic gelation method using single and blends of polymers. Along with usual physical properties, the microspheres were also subjected to enteric nature, in-vitro drug release and mucoadhesion studies to investigate a possible sustained drug release and their use in in-vivo as a gastro-protective system for aceclofenac. It was observed that prepared microspheres could be able to restrict the drug release in stomach region and prolong the drug release by adhering on to the intestinal mucosa. In vitro drug release suggested a combination of drug diffusion and spheres erosion could be the release mechanism and it was also found that blend of polymers is more effective in sustaining the drug release than either polymer. Optimized microsphere formulation suggested 71.03 ± 4.94 % edema inhibition at 12 hours and shelf life of about 2.32 years at room temperature. Algino-gelatin multiunit dosage system exhibits promising properties for once daily targeted release form of aceclofenac in order to reduce the side effects and enhance the patient’s compliance.
Export Options
About this article
Cite this article as:
Chakraborty Santanu, Khandai Madhusmruti and Ghosh Kumar Ashoke, Design, Characterization and Pre-Clinical Evaluation of Aceclofenac Loaded Algino-gelatin Microspheres for Targeted Drug Delivery, Drug Delivery Letters 2013; 3 (2) . https://dx.doi.org/10.2174/2210303111303020001
DOI https://dx.doi.org/10.2174/2210303111303020001 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Prolactin Receptor Antagonists: Same Goal, Different Ways
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Emerging Role of GPR30/GPER1 in Skeletal Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets Pertinence of Apoptosis Markers for the Improvement of In Vitro Fertilization (IVF)
Current Medicinal Chemistry Marine Peptides and Related Compounds in Clinical Trial+
Anti-Cancer Agents in Medicinal Chemistry Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Nimesulide is a Selective COX-2 Inhibitory, Atypical Non-Steroidal Anti-Inflammatory Drug
Current Medicinal Chemistry Molecular Signaling Pathways and Essential Metabolic Elements in Bone Remodeling: An Implication of Therapeutic Targets for Bone Diseases
Current Drug Targets Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Crystallization of Cytochromes P450 and Substrate-Enzyme Interactions
Current Topics in Medicinal Chemistry Modified Release Biodegradable Polymeric Microspheres of Stavudine: Cell Viability, Cellular Uptake, Hemolysis Studies and In Vivo Pharmacokinetics
Current HIV Research Preface
Mini-Reviews in Medicinal Chemistry Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
Current Medicinal Chemistry Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents
Current Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery The Mechanism of Memory Impairment Induced by Aβ Chronic Administration Involves Imbalance between Cytokines and Neurotrophins in the Rat Hippocampus
Current Alzheimer Research Dietary Polyphenols for Treatment of Alzheimer’s Disease– Future Research and Development
Current Pharmaceutical Biotechnology Yeast as a Powerful Model System for the Study of Apoptosis Regulation by Protein Kinase C Isoforms
Current Pharmaceutical Design Design and Synthesis of Novel Diaryl Heterocyclic Derivatives as Selective Cyclooxygenase-2
Letters in Drug Design & Discovery What Characterizes Endothelial Dysfunction in Preeclampsia? -The Action of NO and the Production of Prostacyclin is Reduced, While EDHF is Preserved in Omental Resistance Arteries in Preeclamptic Women
Current Women`s Health Reviews